GKOS Glaukos Corporation

57.92
+0.57  (+1%)
Previous Close 57.35
Open 57.2
Price To Book 13.19
Market Cap 2,509,262,658
Shares 43,322,905
Volume 339,608
Short Ratio 17.56
Av. Daily Volume 450,480
Stock charts supplied by TradingView

NewsSee all news

  1. Glaukos Announces Participation in J.P. Morgan Healthcare Conference

    Glaukos Corporation (NYSE:GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Latest News

  1. Glaukos Announces Participation in J.P. Morgan Healthcare Conference

    Glaukos Corporation (NYSE:GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its